All Posts Tagged With: "London"

Link: http://drjimmyscott.com/?m=201104

Excerpt:

The Health Hazards of Disease Prevention
A Personal Viewpoint by Damien Downing, M.D., London, U.K.

(OMNS Apr 8, 2011) “No pharmaceutical drug is devoid of risks from adverse reactions and vaccines are no exception. Vaccination is a medical intervention and should be carried out with the informed consent of those who are being subjected to it.” (Dr. Lucija Tomljenovic, University of British Columbia.) 

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21117376&retmode=ref&cmd=prlinks

Excerpt:

Lyme disease is rare in the U.K. but there is evidence of an increase in
both prevalence of, and patient concern about, the infection. There are no
published data characterising Lyme disease as it is seen in the U.K. The
clinical and laboratory features of 65 patients diagnosed with the disease
between 2002 and
2007 were recorded and their clinical presentation and response to treatment
documented. In total, 34% of patients acquired the infection in the UK, 20%
in North America and 46% in Europe. Exposure to ticks was reported by 58% of
patients. Erythema migrans was seen in 91%, systemic upset in 62%, headaches
in 31%, arthralgia or arthritis in 28%, radiculitis in 11% and cranial nerve
palsies in 4.6%. Screening enzyme immunoassay tests were negative in 39% and
reference laboratory immunoblots were negative in 31% of patients,
principally those with early infection. The majority of patients were cured
with one course of antibiotic treatment, three patients had evidence of
persistent infection after treatment and two required intravenous therapy.
No cases of chronic Lyme disease were seen.

Traditional Chinese medicine commands a unique position among all traditional medicines because of its 5000 years of history. Our own interest in natural products from traditional Chinese medicine was triggered in the 1990s, by artemisinin‐type sesquiterpene lactones from Artemisia annua L. As demonstrated in recent years, this class of compounds has activity against malaria, cancer cells, and schistosomiasis. Interestingly, the bioactivity of artemisinin and its semisynthetic derivative artesunate is even broader and includes the inhibition of certain viruses, such as human cytomegalovirus and other members of the Herpesviridae family (e.g., herpes simplex virus type 1 and Epstein‐Barr virus), hepatitis B virus, hepatitis C virus, and bovine viral diarrhea virus. Analysis of the complete profile of the pharmacological activities and molecular modes of action of artemisinin and artesunate and their performance in clinical trials will further elucidate the full antimicrobial potential of these versatile pharmacological tools from nature. Continued